McDermott Will & Schulte

McDermott Will & Schulte is a Top 25 Am Law firm with approximately 1,750 lawyers across 20+ global offices. The firm provides comprehensive legal services with notable strength in healthcare law, private equity, and corporate transactions. Formed through a merger, the firm combines deep regulatory expertise with transactional capabilities.

The firm's healthcare practice focuses on regulatory compliance, M&A advisory, telemedicine frameworks, and investment strategies. They counsel clients on evolving capital structures, controlled substance prescribing regulations, and creative investment opportunities in the healthcare sector. Their approach integrates cross-border transaction experience with sector-specific regulatory knowledge.

McDermott Will & Schulte has earned recognition as Law360's 2024 Practice Group of the Year in three categories including Healthcare and Benefits. The firm maintains 125+ Chambers-ranked practices across two continents and hosts industry-specific events including the annual Healthcare Private Equity Conference in Miami.

Organizations should consider McDermott Will & Schulte when facing complex healthcare transactions, regulatory challenges requiring multi-jurisdictional expertise, or strategic initiatives involving private capital. The firm excels in scenarios where healthcare regulatory knowledge must integrate with sophisticated corporate and transactional capabilities.

Clients can expect high-touch service from experienced healthcare attorneys, access to cross-practice resources for comprehensive deal support, and insights informed by the firm's position at the intersection of healthcare regulation and private equity investment trends.

McDermott Will & Schulte maintains a dedicated Healthcare practice recognized as Law360's 2024 Practice Group of the Year. The firm advises across healthcare subsectors including hospitals, health systems, digital health, payers, pharma, and medical devices. Their healthcare attorneys provide regulatory guidance on telemedicine frameworks, controlled substance prescribing, HIPAA compliance, and value-based care structures.

The firm's healthcare work emphasizes M&A transactions, private equity investments, and creative capital strategies specific to healthcare's evolving regulatory landscape. They host the annual Healthcare Private Equity Conference and publish regular insights on healthcare investment trends, regulatory developments, and policy changes affecting the sector.

Mid-to-large healthcare organizations, health systems, private equity firms with healthcare investment portfolios, digital health companies preparing for significant funding or M&A events, pharmaceutical companies, and payers requiring sophisticated regulatory and transactional counsel. Organizations must have budgets appropriate for premium legal services and complex multi-faceted legal needs.